ID
19577
Description
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00320541
Link
https://clinicaltrials.gov/show/NCT00320541
Keywords
Versions (1)
- 1/11/17 1/11/17 -
Uploaded on
January 11, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00320541
Eligibility Breast Cancer NCT00320541
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00320541
- StudyEvent: Eligibility
C0027627 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C0178784 (UMLS CUI [3,2])
C0449381 (UMLS CUI [1,2])
C0205476 (UMLS CUI [1,3])
C2986665 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,2])
C2987220 (UMLS CUI [2,1])
C0884358 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
C0849535 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1299582 (UMLS CUI [1,2])